Ioana C. Hone

Ioana C. Hone is a seasoned professional in investor relations and corporate communications, currently serving as Senior Director at Lineage Cell Therapeutics since September 2018. With a strong background that includes founding HGI, a consultancy focused on investor relations and strategic branding, Ioana has held various advisory roles across multiple companies such as Artelo Biosciences, T-Cure Biosciences, and Savara Inc., where responsibilities encompassed managing global investor relations programs and enhancing corporate communications. Previous experience also includes consulting roles at LifeVantage Corporation and Mast Therapeutics, contributing significantly to capital-raising efforts and strategic transactions. Ioana holds a Bachelor of Arts in International Studies with a minor in Political Science from UC Irvine.